Drug details:
Molecular formula: C₁₄H₉Br₂N₃O₄

Standard name: N-[(3,5-dibromo-2-hydroxyphenyl)methylideneamino]-4-nitrobenzamide

Synonyms:

n'-(3,5-dibromo-2-hydroxybenzylidene)-4-nitrobenzohydrazide N-[(3,5-Dibromo-2-hydroxyphenyl)methylideneamino]-4-nitrobenzamide

Curated SMILES: O=C(NN=CC1=CC(Br)=CC(Br)=C1O)C1=CC=C([N+](=O)[O-])C=C1

Evidence for compound's anti-virulence activity:

Chlamydia
Related VF: TTSS (Type III secretion system)
Target: Not determined
Drug effect: Inhibits T3SS activity and disrupts progression of the chlaymdial development cycle.
Max phase: Preclinical (in vitro)
Publication:
Wolf K, et al., 2006. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol Microbiol 61(6):1543-55.